199 related articles for article (PubMed ID: 23151446)
1. Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid.
Shah K; Connolly RJ; Chapman T; Jaroszeski MJ; Ugen KE
Hum Vaccin Immunother; 2012 Nov; 8(11):1722-8. PubMed ID: 23151446
[TBL] [Abstract][Full Text] [Related]
2. Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation.
Ugen KE; Kutzler MA; Marrero B; Westover J; Coppola D; Weiner DB; Heller R
Cancer Gene Ther; 2006 Oct; 13(10):969-74. PubMed ID: 16763607
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of anti-melanoma activity of a plasmid expressing HIV-1 Vpr delivered through in vivo electroporation.
McCray AN; Ugen KE; Heller R
Cancer Biol Ther; 2007 Aug; 6(8):1269-75. PubMed ID: 17700061
[TBL] [Abstract][Full Text] [Related]
4. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
Lucas ML; Heller L; Coppola D; Heller R
Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
[TBL] [Abstract][Full Text] [Related]
5. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
6. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
[TBL] [Abstract][Full Text] [Related]
7. Delivery of interleukin-15 to B16 melanoma by electroporation leads to tumor regression and long-term survival.
Marrero B; Shirley S; Heller R
Technol Cancer Res Treat; 2014 Dec; 13(6):551-60. PubMed ID: 24000979
[TBL] [Abstract][Full Text] [Related]
8. Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanoma.
Komel T; Bosnjak M; Kranjc Brezar S; De Robertis M; Mastrodonato M; Scillitani G; Pesole G; Signori E; Sersa G; Cemazar M
Bioelectrochemistry; 2021 Oct; 141():107843. PubMed ID: 34139572
[TBL] [Abstract][Full Text] [Related]
9. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
[TBL] [Abstract][Full Text] [Related]
10. Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.
Kim H; Sin JI
Hum Vaccin Immunother; 2012 Nov; 8(11):1714-21. PubMed ID: 23151450
[TBL] [Abstract][Full Text] [Related]
11. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
12. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.
Burkart C; Mukhopadhyay A; Shirley SA; Connolly RJ; Wright JH; Bahrami A; Campbell JS; Pierce RH; Canton DA
Gene Ther; 2018 Apr; 25(2):93-103. PubMed ID: 29523878
[TBL] [Abstract][Full Text] [Related]
13. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
[TBL] [Abstract][Full Text] [Related]
14. Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model.
Kamensek U; Cemazar M; Lampreht Tratar U; Ursic K; Sersa G
Cancer Immunol Immunother; 2018 May; 67(5):785-795. PubMed ID: 29468364
[TBL] [Abstract][Full Text] [Related]
15. Sequence and time dependence of transfection efficiency of electrically-assisted gene delivery to tumors in mice.
Cemazar M; Pavlin D; Kranjc S; Grosel A; Mesojednik S; Sersa G
Curr Drug Deliv; 2006 Jan; 3(1):77-81. PubMed ID: 16472096
[TBL] [Abstract][Full Text] [Related]
16. In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
Wang G; Tschoi M; Spolski R; Lou Y; Ozaki K; Feng C; Kim G; Leonard WJ; Hwu P
Cancer Res; 2003 Dec; 63(24):9016-22. PubMed ID: 14695220
[TBL] [Abstract][Full Text] [Related]
17. Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery.
Zaharoff DA; Barr RC; Li CY; Yuan F
Gene Ther; 2002 Oct; 9(19):1286-90. PubMed ID: 12224011
[TBL] [Abstract][Full Text] [Related]
18. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
[TBL] [Abstract][Full Text] [Related]
19. Plasmid injection and application of electric pulses alter endogenous mRNA and protein expression in B16.F10 mouse melanomas.
Heller LC; Cruz YL; Ferraro B; Yang H; Heller R
Cancer Gene Ther; 2010 Dec; 17(12):864-71. PubMed ID: 20706286
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of DNA Sensors in B16.F10 Melanoma Spheroid Cells After Electrotransfer of pDNA.
Znidar K; Bosnjak M; Jesenko T; Heller LC; Cemazar M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818780088. PubMed ID: 29879868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
